Abstract:Objective The purpose of the study is to explore the mechanism of NRAGE enhancing radioresistance of esophageal squamous cell carcinoma (ESCC) in 2D and 3D levels. Methods Stably NRAGE-overexpressed ESCC cells and 3D-printing models for ESCC cells were established. Then, cellular malignancy indexes, such as cell morphology, proliferation, radioresistance, motility, apoptosis, cell cycle, and proteins of the Wnt/β-catenin pathway, were compared between radioresistant and its parental cells in 2D and 3D levels. Additionally, 44 paraffin ESCC specimens with radical radiotherapy were selected to examine NRAGE and β-catenin protein expression and analyze the clinical correlation. Results Experiments in 2D culture showed that morphology of the Eca109/NRAGE cells was more irregular, elongated spindle-shaped and disappeared polarity. It obtained faster growth ability, stronger resistance to irradiation, enhanced motility, reduced apoptosis ratio and cell cycle rearrangement. Moreover, Western blot results showed β-catenin, p-Gsk-3β and CyclinD1 expressions were induced, while p-β-catenin and Gsk-3β expressions decreased in Eca109/NRAGE cells. Experiments in the 3D-printing model showed Eca109/NRAGE cell-laden 3D scaffolds had the advantage on growth and spheroiding according to the brightfield observation, scanning electron microscopy and Ki-67 IHC staining, and higher expression at the β-catenin protein. Clinical analysis showed that NRAGE expression was higher in tumor tissues than in control tissues of ESCC patients from the Public DataBase. Compared with radiotherapy effective group, both NRAGE total and nuclear and β-catenin nuclear expressions were significantly upregulated from ESCC specimens in invalid group. Further analysis showed a positive and linear correlation between NRAGE nuclear and β-catenin nuclear expressions. Additionally, results from univariate and multivariate analyses revealed NRAGE nuclear expression could serve as a risk factor for ESCC patients receiving radical radiotherapy. Conclusion ESCC cells with NRAGE nuclear accumulation demonstrated greater radioresistance, which may be related to the activation of the Wnt/β-catenin signaling pathway. It indicated that NRAGE nuclear expression was a potential biomarker for monitoring radiotherapeutic response.

Knockdown of NRAGE Impairs Homologous Recombination Repair and Sensitizes Hepatoblastoma Cells to Ionizing Radiation.

NRAGE is Involved in Homologous Recombination Repair to Resist the DNA-damaging Chemotherapy and Composes a Ternary Complex with RNF8–BARD1 to Promote Cell Survival in Squamous Esophageal Tumorigenesis

NRAGE Promotes Cell Proliferation by Stabilizing PCNA in a Ubiquitin-Proteasome Pathway in Esophageal Carcinomas.

NRAGE Confers Radiation Resistance in 2D and 3D Cell Culture and Poor Outcome in Patients With Esophageal Squamous Cell Carcinoma

The Effect of NRAGE on Cell Cycle and Apoptosis of Human Dental Pulp Cells and MDPC-23.

NRAGE Confers Poor Prognosis and Promotes Proliferation, Invasion, and Chemoresistance in Gastric Cancer.

NRAGE suppresses metastasis of melanoma and pancreatic cancer in vitro and in vivo.

Human NRAGE Disrupts E-cadherin/β-catenin Regulated Homotypic Cell–cell Adhesion

A Novel NGR-conjugated Peptide Targets DNA Damage Responses for Radiosensitization.

RNF216 Alleviates Radiation-Induced Apoptosis and DNA Damage Through Regulating Ubiquitination-Mediated Degradation of p53 in Glioblastoma

RNF8 plays an important role in the radioresistance of human nasopharyngeal cancer cells in vitro.

hNRAGE, a human neurotrophin receptor interacting MAGE homologue, regulates p53 transcriptional activity and inhibits cell proliferation.

RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site

Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy

Quantitative Proteomic Analysis Identifies MAPK15 As a Potential Regulator of Radioresistance in Nasopharyngeal Carcinoma Cells

The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment

Rad51 in regulating the radiosensitivity of non-small cell lung cancer with different epidermal growth factor receptor mutation status.

AEG-1 Knockdown Sensitizes Glioma Cells to Radiation Through Impairing Homologous Recombination Via Targeting RFC5

Role of the NRP-1-mediated VEGFR2-independent pathway on radiation sensitivity of non-small cell lung cancer cells

Promoting Tumorigenesis in Nasopharyngeal Carcinoma, NEDD8 Serves As a Potential Theranostic Target

Gli-1/Pi3k/Akt/Nf-Kb Pathway Mediates Resistance to Radiation and is A Target for Reversion of Responses in Refractory Acute Myeloid Leukemia Cells